Sale!

TMEM173 Gene Vasculopathy Infantile-Onset TMEM173/STING Related NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The TMEM173 Gene Vasculopathy Infantile-Onset TMEM173/STING Related NGS Genetic DNA Test is a comprehensive genetic analysis that detects mutations in the TMEM173 gene associated with rare infantile-onset vasculopathy disorders. This advanced next-generation sequencing test identifies genetic variations that cause inflammatory conditions affecting blood vessels, skin, bones, and immune system function. The test is crucial for infants and children presenting with unexplained skin lesions, recurrent fevers, joint inflammation, and developmental abnormalities. By providing precise genetic diagnosis, this $500 USD test enables targeted treatment approaches and helps families understand inheritance patterns. Our specialized genetic testing service offers detailed clinical correlation and professional genetic counseling support.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

TMEM173 Gene Vasculopathy Infantile-Onset TMEM173/STING Related NGS Genetic DNA Test

Comprehensive Genetic Analysis for Rare Vasculopathy Disorders

The TMEM173 Gene Vasculopathy Infantile-Onset TMEM173/STING Related NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations responsible for rare inflammatory vasculopathy conditions that typically manifest in infancy. This specialized genetic test utilizes next-generation sequencing technology to provide comprehensive analysis of the TMEM173 gene, which plays a critical role in regulating the STING (stimulator of interferon genes) pathway and maintaining immune system homeostasis.

What This Advanced Genetic Test Measures

Our comprehensive NGS genetic test specifically targets and analyzes the TMEM173 gene to detect pathogenic variants associated with:

  • Mutations in the TMEM173 gene encoding the STING protein
  • Genetic variations causing constitutive activation of the STING pathway
  • Specific nucleotide changes linked to infantile-onset vasculopathy
  • Inheritance patterns and familial genetic risk factors
  • Potential therapeutic targets based on genetic findings

Who Should Consider This Genetic Testing

This specialized genetic test is recommended for infants and children presenting with the following clinical features:

  • Unexplained skin vasculitis or cutaneous lesions appearing in infancy
  • Recurrent febrile episodes without clear infectious causes
  • Arthritis or joint inflammation in early childhood
  • Developmental delays or failure to thrive
  • Family history of similar autoimmune or inflammatory conditions
  • Persistent inflammatory markers in blood tests
  • Unusual bone abnormalities or skeletal changes
  • Immune system dysregulation symptoms

Significant Benefits of Genetic Testing

Undergoing the TMEM173 Gene Vasculopathy NGS Genetic DNA Test provides numerous clinical advantages:

  • Accurate Diagnosis: Precise identification of the underlying genetic cause enables targeted treatment strategies
  • Early Intervention: Timely diagnosis allows for prompt initiation of appropriate therapies
  • Family Planning: Understanding inheritance patterns helps families make informed reproductive decisions
  • Personalized Treatment: Genetic results guide selection of specific immunomodulatory therapies
  • Prognostic Information: Genetic findings provide insights into disease progression and potential complications
  • Research Contribution: Participation helps advance understanding of rare genetic disorders

Understanding Your Genetic Test Results

Our comprehensive genetic testing report provides detailed interpretation of your results:

  • Positive Result: Indicates the presence of a pathogenic TMEM173 gene mutation, confirming the genetic diagnosis of STING-associated vasculopathy with infantile onset
  • Negative Result: Suggests that no disease-causing mutations were detected in the TMEM173 gene, though clinical correlation remains essential
  • Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation and family studies
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

Test Pricing Information

Test Description Price (USD)
TMEM173 Gene Vasculopathy Infantile-Onset TMEM173/STING Related NGS Genetic DNA Test – Discount Price $500
TMEM173 Gene Vasculopathy Infantile-Onset TMEM173/STING Related NGS Genetic DNA Test – Regular Price $700

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States with convenient locations in all major metropolitan areas including New York City, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified genetic counselors and specialized laboratories ensures consistent, high-quality testing standards nationwide.

Schedule Your Genetic Test Today

Take the first step toward accurate diagnosis and personalized treatment planning. Our experienced genetic specialists are ready to guide you through the testing process and provide comprehensive result interpretation. Contact us today to schedule your TMEM173 Gene Vasculopathy Infantile-Onset TMEM173/STING Related NGS Genetic DNA Test.

Call or WhatsApp: +1(267) 388-9828

Our dedicated team will assist you with test scheduling, insurance verification, and answer any questions about the genetic testing process. Early genetic diagnosis can significantly impact treatment outcomes and quality of life for affected individuals.